2009-09-02
Pfizer Inc. ignored a 2005 FDA Warning Letter to stop promoting its antibiotic Zyvox as clinically superior to the significantly less expensive, generic vancomycin when its own FDA-approved label indicated otherwise. The drug giant also defrauded federal and state taxpayers by marketing Zyvox off-label, according to a qui fam whistleblower complaint filed by Sheller, p.C. attorneys and other documents unsealed with today’s $2.3 billion Pfizer settlement.
[pdf-embedder url=”http://sheller.com/wp-content/uploads/2009/09/Sheller_Pfizer_2.3b_Verdict.pdf”]
